IMPACT OF INTERLEUKIN 17 BLOCKING AGENT ON CLINICAL OUTCOME IN SAPHO PATIENTS
Assmann G, Bittenbring JT, Wagner AD, Schreiber M, Christofyllakis K, Hüffmeier U, Pfoehler C, Neumann F (2019)
Publication Type: Conference contribution
Publication year: 2019
Journal
Publisher: BMJ PUBLISHING GROUP
City/Town: LONDON
Pages Range: 875-876
Conference Proceedings Title: ANNALS OF THE RHEUMATIC DISEASES
Event location: Madrid
DOI: 10.1136/annrheumdis-2019-eular.4145
Authors with CRIS profile
Involved external institutions
Universitätsklinikum des Saarlandes (UKS)
Germany (DE)
Universität des Saarlandes (UdS)
Germany (DE)
Medizinische Hochschule Hannover (MHH) / Hannover Medical School
Germany (DE)
Germany (DE)
Universität des Saarlandes (UdS)
Germany (DE)
Medizinische Hochschule Hannover (MHH) / Hannover Medical School
Germany (DE)
How to cite
APA:
Assmann, G., Bittenbring, J.T., Wagner, A.D., Schreiber, M., Christofyllakis, K., Hüffmeier, U.,... Neumann, F. (2019). IMPACT OF INTERLEUKIN 17 BLOCKING AGENT ON CLINICAL OUTCOME IN SAPHO PATIENTS. In ANNALS OF THE RHEUMATIC DISEASES (pp. 875-876). Madrid, ES: LONDON: BMJ PUBLISHING GROUP.
MLA:
Assmann, Gunter, et al. "IMPACT OF INTERLEUKIN 17 BLOCKING AGENT ON CLINICAL OUTCOME IN SAPHO PATIENTS." Proceedings of the Annual European Congress of Rheumatology (EULAR), Madrid LONDON: BMJ PUBLISHING GROUP, 2019. 875-876.
BibTeX: Download